Article
HIV-1 genotype and phenotype correlate with virological response to abacavir, amprenavir and efavirenz in treatment-experienced patients.
AIDS (London, England) - 15 Feb 2002
Falloon Judith, Ait-Khaled Mounir, Thomas Deborah A, Brosgart Carol L, Eron Joseph J, Feinberg Judith, Flanigan Timothy P, Hammer Scott M, Kraus Peter W, Murphy Robert, Torres Ramon, Masur Henry
Abstract excerpt
OBJECTIVE: To assess the safety and efficacy of three new drugs in patients with antiretroviral failure and to correlate retrospectively baseline factors with virological response. DESIGN AND SETTING: Open-label, 48-week, single-arm, multi-center phase II trial conducted at nine US university or government clinics and private practices. PATIENTS AND INTERVENTIONS: Patients with HIV-1 RNA > or =500 copies/ml...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.